Company intelligence / Profile preview
Boryung
Seoul, South Koreaboryung.co.kr ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Boryung has successfully commercialized several blockbuster drugs such as Kanarb® (Fimasartan) for hypertension—the first domestically developed ARB in South Korea—and continues to expand its pipeline into oncology and advanced therapies. The company has global partnerships for Kanarb in over 50 countries. It also develops APIs and combination therapies targeting cardiovascular diseases and other major health burdens. Recent innovation includes a microneedle patch containing donepezil granted patent status.
- Therapeutic areas
- OncologyCardiovascularEndocrinologyNeurology
- Modalities
- Small moleculesCombination drugsGene therapyBiopharmaceuticals
- Industry
- Biotech
02
Drug pipeline
59 assets58 more assets in the full pipeline.
03
Partnerships
Global business partnerships for Kanarb in over 50 countries worldwide
04
Financials
- Market cap
- $530.1M
- Total revenue
- $751.6M
- Enterprise value
- $717.6M
Beyond the preview
Go deeper on Boryung.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Boryung.